Advice Pool - Health and Fitness

An aneurysm is a bulge in the wall of an artery. Aneurysms may result from congenital defects, preexisting conditions such as high blood pressure and atherosclerosis (the buildup of fatty deposits in the arteries),

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

or head trauma. Aneurysms most commonly occur in arteries at the base of the brain and in the aorta. Aneurysms may involve arteries or veins and have various causes. They are commonly further classified by shape, st

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ructure and location. Cerebral aneurysms occur more commonly in adults than in children but they may occur at any age. They are slightly more common in women than in men. Cerebral aneurysms are also more common in p

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

eople with certain genetic diseases, such as connective tissue disorders and polycystic kidney disease, and certain circulatory disorders, such as arteriovenous malformations. Some investigators have speculated that

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

oral contraceptives may increase the risk of developing aneurysms. Aneurysms are dangerous because they may burst. Pain in the area of an aneurysm is a common symptom. The larger an aneurysm becomes, the more likel

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

y it is to burst.

Aneurysms that result from an infection in the arterial wall are called mycotic aneurysms. Cancer-related aneurysms are often associated with primary or metastatic tumors of the head and neck. It

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

is known that men over the age of 60, and younger men with a brother or father who has had an aneurysm, are at risk. It is unclear why a person develops a brain aneurysm. It appears that aneurysms are related to an

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

absence of a muscular layer that makes up part of the blood vessels that over time stretches and thins. An aneurysm may be small and not cause symptoms. An ultrasound examination of the abdomen is a very good way of

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

finding an aneurysm. This is a painless procedure involving a lubricated probe pressing gently on the abdominal skin (over the aneurysm). Many cases of ruptured aneurysm can be prevented with early diagnosis and me

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

dical treatment. Because aneurysms can develop and become large before causing any symptoms, it is important to look for them in people who are at the highest risk.

Causes of Aneurysm

It is not clear exactly what

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

causes aneurysms. Defects in some of the parts of the artery wall may be responsible. An aneurysm can result from atherosclerosis. Cerebral aneurysms occur more commonly in adults than in children but they may occur

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

at any age. They are slightly more common in women than in men. Cerebral aneurysms are also more common in people with certain genetic diseases, such as connective tissue disorders and polycystic kidney disease, an

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

d certain circulatory disorders, such as arteriovenous malformations. Other causes include trauma or injury to the head, high blood pressure, infection, tumors. Some investigators have speculated that oral contracep

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

tives may increase the risk of developing aneurysms.

Symptoms of Aneurysm

There are many symptoms of a brain aneurysm and each person with an aneurysm may not experience the same symptoms. Small, unchanging aneury

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

sms generally will not produce symptoms, whereas a larger aneurysm that is steadily growing may press on tissues and nerves. Before a larger aneurysm ruptures, the individual may experience such symptoms as a sudden

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

and unusually severe headache, nausea, vision impairment, vomiting, and loss of consciousness, or the individual may be asymptomatic, experiencing no symptoms at all. Rupture of a cerebral aneurysm is dangerous and

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

usually results in bleeding into the meninges or the brain itself, leading to a subarachnoid hemorrhage or intracranial hematoma, either of which constitutes a stroke.

Treatment of Aneurysm

Treatment depends on t

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

he size and location of the aneurysm and your overall health. Aneurysms in the upper chest (the ascending aorta) are usually operated on right away. Anticonvulsant medications can prevent seizures, analgesics may re

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

lieve headache symptoms, and calcium channel blockers can help widen narrowed blood vessels. Surgery is also usually required for aneurysms as introducing foreign material in the low flow veins can produce a high ri

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

sk blood clotting environment. Patients who have suffered a subarachnoid hemorrhage often need rehabilitative, speech, and occupational therapy to regain lost function and learn to cope with any permanent disability

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/241556/advicepool-Aneurysm--Causes-Symptoms-and-Treatment.html">Aneurysm - Causes, Symptoms and Treatment</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/241556/advicepool-Aneurysm--Causes-Symptoms-and-Treatment.html]Aneurysm - Causes, Symptoms and Treatment[/url]

Competition in the present day mobile phone industry has run out of hand as phone manufacturers are releasing their products incessantly to cope up with the evolving technology as well as the escalating trends in the market. The surrounding air has become so much intense that there ensues another competition within the confinements of a manufacturer's gallery.

SBS Transit has announced the resignation of Executive Director Mr Ong Boon Leong, who has only been appointed as executive director in 2005. This should be a sudden news for most people. His departure could also be sensitive in view of the ongoing public transport industry review and the rumoured merger between the two land transport rivals, ComfortDelGro and SMRT.

We are not perfect, we don't agree on all things, and we still work through issues even after being married for nearly thirty-six years. Thirty-six years. And we still enjoy it -- LOL!

Tags

Links

Advice Pool - Aneurysm - Causes, Symptoms and Treatment

Related Articles: